Here's Why PGIM Jennison Health Sciences Fund Reduced its Position in Marinus Pharmaceuticals (MRNS) [Yahoo! Finance]
Marinus Pharmaceuticals, Inc. (MRNS)
Last marinus pharmaceuticals, inc. earnings: 11/6 07:30 am
Check Earnings Report
US:NASDAQ Investor Relations:
ir.marinuspharma.com/investor-relations
Company Research
Source: Yahoo! Finance
PGIM Jennison Health Sciences Fund highlighted stocks like Marinus Pharmaceuticals, Inc. (NASDAQ: MRNS ), in the second quarter 2024 investor letter. Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS) is a pharmaceutical company. The one-month return of Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS) was 22.30%, and its shares lost 78.56% of their value over the last 52 weeks. On October 2, 2024, Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS) stock closed at $1.70 per share with a market capitalization of $93.643 million. PGIM Jennison Health Sciences Fund stated the following regarding Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS) in its Q2 2024 investor letter: "Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS) is a biopharmaceutical company focused on the development of Ganaxolone, a GABA_A receptor modulating mechanism intended to treat various forms of epilepsy. Their approved asset, Ztalmy, launched in July 2022 and is an oral suspension formulation of Ganaxolone for Cyclin-dependent kinase-like
Show less
Read more
Impact Snapshot
Event Time:
MRNS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
MRNS alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
MRNS alerts
High impacting Marinus Pharmaceuticals, Inc. news events
Weekly update
A roundup of the hottest topics
MRNS
News
- Marinus Pharmaceuticals, Inc. (NASDAQ: MRNS) was upgraded by analysts at StockNews.com from a "sell" rating to a "hold" rating.MarketBeat
- Marinus Pharmaceuticals, Inc. (NASDAQ: MRNS) was upgraded by analysts at EF Hutton Acquisition Co. I to a "strong-buy" rating.MarketBeat
- Marinus Pharmaceuticals, Inc. (NASDAQ: MRNS) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.MarketBeat
- Great week for Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS) institutional investors after losing 78% over the previous year [Yahoo! Finance]Yahoo! Finance
- Marinus Pharmaceuticals, Inc. (NASDAQ: MRNS) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $13.00 price target on the stock.MarketBeat
MRNS
Earnings
- 8/13/24 - Miss
MRNS
Sec Filings
- 10/2/24 - Form 8-K
- 9/20/24 - Form 8-K
- 8/13/24 - Form 10-Q
- MRNS's page on the SEC website